Abrogating K458 acetylation enhances hepatocyte nuclear factor 4α (HNF4α)-induced differentiation therapy for hepatocellular carcinoma.

Saved in:
Bibliographic Details
Title: Abrogating K458 acetylation enhances hepatocyte nuclear factor 4α (HNF4α)-induced differentiation therapy for hepatocellular carcinoma.
Authors: Liu F; Department of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China., Peng Y; Department of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China., Qian H; Department of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China., Xiao MC; Department of Gastroenterology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China., Ding CH; Department of Gastroenterology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China., Zhang X; Department of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China., Xie WF; Department of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China.
Source: Journal of digestive diseases [J Dig Dis] 2024 Apr; Vol. 25 (4), pp. 255-265.
Publication Type: Journal Article
Journal Info: Publisher: Blackwell Pub. Asia Country of Publication: Australia NLM ID: 101302699 Publication Model: Print Cited Medium: Internet ISSN: 1751-2980 (Electronic) Linking ISSN: 17512972 NLM ISO Abbreviation: J Dig Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1751-2980
DOI:10.1111/1751-2980.13272